3D Systems Corp (DDD) shares experienced a significant surge, climbing by 6.46% to $2.55 on Tuesday afternoon. The catalyst behind this rally was the company’s announcement of receiving FDA clearance for its revolutionary monolithic jetted denture solution. This groundbreaking technology promises to transform denture production for dental laboratories, streamlining the process and potentially boosting efficiency.
3D Systems highlighted that the FDA clearance empowers dental labs to enhance denture production efficiency. This move has already garnered the attention of key players in the industry. Glidewell, a prominent manufacturer of restorative dental devices, has already begun integrating this innovative technology into its production workflow. Stephenie Goddard, CEO of Glidewell, expressed enthusiasm about implementing 3D Systems’ new workflow, stating, “We look forward to implementing 3D Systems’ new workflow.”
Neil McCaffrey, Vice President and General Manager of Dental at 3D Systems, emphasized the significance of this FDA clearance, stating that it aligns perfectly with the company’s broader strategy to expand its digital dentistry portfolio. The company is poised to leverage its expertise in hardware, software, and materials technology to create a streamlined production process for its new denture solution.
The positive reception of this news underscores the growing demand for innovative solutions within the dental industry. As 3D Systems continues to expand its digital dentistry offerings, investors are closely watching to see how this technology will reshape the future of denture production.
